Human Genome Sciences Added To American Stock Exchange's Biotechnology Index
ROCKVILLE, Md., April 18 /PRNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it will be added to the Biotechnology Index at the American Stock Exchange after the close of business on April 20, 2000. HGSI will be one of 17 companies in the index.
The Index, traded under the symbol BTK, is an equal dollar weighted index designed to measure the performance of a cross-section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or to provide services. The index was developed with a base level of 200 as of October 18, 1991.
Human Genome Sciences is a company with the mission to treat and cure disease by bringing new gene-based drugs to patients.
HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company's web site at www.hgsi.com. Copies of HGSI press releases are also available by fax 24 hours a day at no charge by calling 800/758-5804, ext. 121115.
Any statements released by Human Genome Sciences, Inc. that are forward looking are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Readers are cautioned that forward looking statements involve risks and uncertainties which may affect the company's business prospects and performance. These include economic, competitive, governmental, technological and other factors discussed in the company's filings with the Securities and Exchange Commission on forms 10-K, 10-Q and 8-K.
SOURCE Human Genome Sciences
CO: Human Genome Sciences; American Stock Exchange
ST: Maryland, New York
IN: FIN BIO MTC
SU:
04/18/2000 14:54 EDT prnewswire.com |
